Spero Therapeutics, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Spero Therapeutics, Inc. (SPRO) had Common Stock, Capital Shares Reserved for Future Issuance of 7.15 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-12
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 7.15M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 7.23M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 8.79M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 6.60M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 7.15M shares 10-Q · filed 2026-08-12 |
| 2026-03-31 | 7.23M shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 8.79M shares 10-K · filed 2026-03-26 |
| 2024-12-31 | 6.60M shares 10-K · filed 2025-03-27 |
| 2023-12-31 | 5.24M shares 10-K · filed 2024-03-13 |
| 2023-09-30 | 2.80M shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 2.08M shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 2.20M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 5.41M shares 10-K · filed 2023-03-30 |
| 2022-09-30 | 4.81M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 2.64M shares 10-Q · filed 2022-08-10 |
| 2022-03-31 | 1.14M shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 2.70M shares 10-K · filed 2022-03-31 |
| 2021-09-30 | 2.93M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 463.63K shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 495.40K shares 10-Q · filed 2021-05-06 |
| 2020-12-31 | 769.93K shares 10-K · filed 2021-03-11 |
| 2020-09-30 | 935.50K shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 973.47K shares 10-Q · filed 2020-08-06 |
| 2020-03-31 | 323.92K shares 10-Q · filed 2020-05-08 |
| 2019-12-31 | 489.66K shares 10-K · filed 2020-03-16 |
| 2019-09-30 | 371.44K shares 10-Q · filed 2019-11-04 |
| 2019-06-30 | 376.60K shares 10-Q · filed 2019-08-08 |
| 2019-03-31 | 435.49K shares 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |